Skip to main content

International Psoriasis Council

International Psoriasis Council
subscribe
6   What's New
Search
subscribe
Search

Advancing Knowledge. Improving Care.

World Psoriasis Day 2023: Empowering Access to Timely Treatment and Universal Healthcare from Psoriasis Advocates Worldwide

World Psoriasis Day serves as a reminder of the critical need for accessible and timely treatment for those affected by this often misunderstood disease. As the International Psoriasis Council (IPC) reiterates its commitment to access to care for all, the importance of universal healthcare takes center stage in the battle against psoriasis. Within our global network, dedicated advocates are tirelessly working to bridge the gap and ensure that everyone has equal access to comprehensive and timely care regardless of their background.

1. What does the right treatment at the right time mean to you?

Understanding the disease from the patient's perspective and a patient-centric approach is key when selecting the optimal treatment for each patient. We, as dermatologists, want an effective, safe, and long-lasting treatment. On the other hand, patient convenience and patients’ preference for an oral or injectable medication are important considerations to be taken into account. Maria-Angeliki Gkini, MD, MSc, PhD | United Kingdom 2023 IPC Fellow
In my opinion, receiving the right treatment at the right time can minimize the pain caused by psoriasis, enhance patients' confidence in treatment, and prevent the progression of the disease and the occurrence of comorbidities. Xuejun Zhang, MD, PhD | China IPC Councilor

2. What does universal healthcare mean to your patients?

Universal healthcare would mean that my patients can access quality and affordable healthcare wherever they are without having to travel all the way to the National Hospital to access Dermatologists and drugs. Priscilla Angwenyi, MD | Kenya 2023 IPC Fellow

3. What are psoriasis advocates doing in your country to promote access for all?

Dermatologists, patient associations, and also pharma are talking to relevant actors in our Ministry of Health, senators and deputies, other doctors, and the community to teach the problems of psoriasis and its possible solutions and raise awareness about the need for help. Fernando Valenzuela, MD | Chile IPC Councilor

Please take a moment to share your insights on these vital questions in the comment section below. Your voice matters in the global dialogue on psoriasis care. Let’s continue working together for a world where accessible healthcare is a reality for all.

Comments are closed.

Categories

Recent Posts

Psoriasis and Metabolic Health: What IPC’s Latest Publication Means for Clinical Practice

VIEW

Challenging Patient Interactions: What’s Really Behind the ‘Difficult’ Label — A Conversation with Dr. John Koo

VIEW

IPC Welcomes New Councilors Dr. Steven Fakharzadeh and Dr. Rodrigo Garcia Salinas

VIEW

Also Read

Subscribe to the IPC Newsletter

Stay up-to-date on the latest research, news, and upcoming events right in your inbox.
Subscribe

What's New

Global and Collaborative Research in Psoriasis: IPC Fellows Research Class #1 Recordings

Recordings from the IPC Fellows Research Class #1: Global and Collaborative Research in Psoriasis are now available. Program Chairs Peter van de Kerkhof, MD, PhD, and María Julia Cura, MD, led a faculty of international experts through sessions on unresolved questions in the era of effective psoriasis therapies, building global research collaborations, and connecting psoriasis research across disciplines. Watch to hear from Wolf Henning Boehncke, MD, MA, Christopher Griffiths, OBE, MD, FMedSci, and Georg Stingl, MD, as they share perspectives shaping the next generation of psoriasis research.

WATCH NOW

Wednesday, July 15, 2026

New in the IPC Resource Library: Research Skills

The IPC Resource Library now includes a dedicated Research Skills category, bringing together videos, articles, and presentations focused on building stronger research capabilities in psoriasis. Browse the current collection to find resources on topics from collaborative research methods to career development for researchers at every stage.

WATCH NOW

Thursday, July 13, 2026

New Take Tens on Psoriatic Arthritis

IPC Councilor Anna Lopez Ferrer, MD, PhD, reviews PURE-4, a four-item tool that helps dermatologists screen psoriasis patients for psoriatic arthritis (PsA) risk. She traces its evolution across three studies (2018–2026) into a validated predictor of early PsA.

IPC Councilor André Lucas Ribeiro, MD, reframes PsA as a slow transition from psoriasis, not a sudden event, opening the door to disease interception. He outlines the steps needed to get there, from harmonizing definitions to reducing inflammatory burden.

WATCH NOW

Wednesday, July 8, 2026